Recursion Pharmaceuticals Inc vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Recursion Pharmaceuticals Inc trades at $3.22 (market cap $1.74B), while Direxion Daily Semiconductor Bull 3X Shares trades at $121.38. The key difference: Direxion Daily Semiconductor Bull 3X Shares is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RXRX | SOXL | |
|---|---|---|
Market Cap | $1.74B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $6.79 | $300.77 |
52-Week Low | $2.84 | $28.60 |
Enterprise Value | $1.26B | — |
Signals from Pluang's Aura AI — not financial advice
RXRX trades at $3.44, down 5.23% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 earnings miss with revenue of $54M and net loss of -$519M, though it maintains partnerships with Genentech and Sanofi. Analyst consensus shows 40% buy ratings with institutional interest from CalSTRS increasing its stake by 64% in Q2 2026.
Outlook remains speculative with significant losses (-961.97% net margin) offset by AI-driven drug discovery potential. Key risks include cash burn and pipeline delays, while catalysts involve clinical progress. The stock offers high-risk growth exposure in TechBio, dependent on platform validation and partnership milestones.
SOXL, a leveraged ETF tracking semiconductor stocks, trades at $123.37, up 5.19% with a bullish technical signal from moving averages. Recent news highlights ongoing semiconductor investment discussions between the US and South Korea, though tariff concerns and warnings of near-term chip stock declines create volatility. The ETF's performance is closely tied to AI-driven demand and semiconductor sector momentum.
Outlook remains mixed; bullish technicals and strong AI infrastructure demand support upside, but leveraged structure amplifies risks from sector volatility and potential tariff impacts. Investors face significant drawdown risks despite reset entry opportunities after recent corrections.
Trailing returns across standard periods
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →